Search
diatrizoate meglumine/iodipamide (Sinografin)
Tradename: Sinografin.
Indications:
- radiopaque agent use to visualize the uterus
Dosage:
Solution: -diatrizoate meglumine 527 mg & Iodipamide meglumine 268 mg/mL (10 mL)
Adverse effects:
1) anaphylactoid reaction 1-10%
2) (see diatrizoate)
General
pharmacologic combination
References
Kaiser Permanente Northern California Regional Drug
Formulary, 1998
Components
diatrizoate